Phase II trial of single-agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash Meeting Abstract

cited authors

  • Schilder, R. J., Lokshin, A. E., Holloway, R. W., Alvarez, R. D., Pathak, H., Aghajanian, C., Drescher, C. W., Godwin, A. K.

Publication Date

  • June 20, 2007

webpage

published in

category

volume

  • 25

issue

  • 18

WoS Citations

  • 2

WoS References

  • 0